J. Goldman & Co’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $140K | Hold |
67,592
| – | – | ﹤0.01% | 302 |
|
|
2025
Q1 | $149K | Sell |
67,592
-202,508
| -75% | -$446K | ﹤0.01% | 292 |
|
|
2024
Q4 | $413K | Buy |
+270,100
| New | +$413K | 0.01% | 272 |
|
|
2023
Q1 | – | Sell |
-54,000
| Closed | -$135K | – | 304 |
|
|
2022
Q4 | $135K | Sell |
54,000
-320,563
| -86% | -$801K | 0.01% | 240 |
|
|
2022
Q3 | $1.58M | Buy |
+374,563
| New | +$1.58M | 0.08% | 155 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 293 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 346 |
|
|
2018
Q1 | – | Sell |
-65,263
| Closed | -$1.18M | – | 280 |
|
|
2017
Q4 | $1.18M | Buy |
+65,263
| New | +$1.18M | 0.06% | 132 |
|
|
2015
Q3 | – | Sell |
-21,876
| Closed | -$682K | – | 189 |
|
|
2015
Q2 | $682K | Buy |
+21,876
| New | +$682K | 0.04% | 128 |
|